Regulation A · Tier 2 · BPTH
Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. (BPTH) filed a Tier 2 Regulation A offering statement (Form 1-A) on Apr 11, 2025 for up to $5M at $0.535 per security. The SEC qualified the offering on May 29, 2025. Underwriter or broker: D, . and B.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $5M
- Offer price
- $0.535
- Security type
- Equity (common or preferred stock)
- Filed
- Apr 11, 2025
- Qualified
- May 29, 2025
- Ticker
- BPTH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- State
- TX
- Underwriter / broker
- D, ., B, o, r, a, l, C, p, i, t and L
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Apr 11, 2025
- Exit report (Form 1-Z)
- All filings on EDGAR CIK 1133818
Other qualified Biotech & pharma Reg A offerings
- Regen BioPharma IncSep 5, 2025 · $2.5M
- Aibotics, Inc.Jul 1, 2025 · $5M
- Turn Therapeutics Inc.Mar 31, 2025 · $18.1M
- Cytonics CorpMar 14, 2025 · $24M
- Medicus Pharma Ltd.Mar 6, 2025 · $12.2M
- Nok Therapeutics, Inc.Jan 3, 2025 · $10M